Literature DB >> 32423258

Mathematical modeling of the thermal effects of irreversible electroporation for in vitro, in vivo, and clinical use: a systematic review.

Pierre Agnass1,2, Eran van Veldhuisen2, Martin J C van Gemert3, Cees W M van der Geld4, Krijn P van Lienden5, Thomas M van Gulik2, Martijn R Meijerink6, Marc G Besselink2, H Petra Kok1, Johannes Crezee1.   

Abstract

Introduction: Irreversible electroporation (IRE) is a relatively new ablation method for the treatment of unresectable cancers. Although the main mechanism of IRE is electric permeabilization of cell membranes, the question is to what extent thermal effects of IRE contribute to tissue ablation.Aim: This systematic review reviews the mathematical models used to numerically simulate the heat-generating effects of IRE, and uses the obtained data to assess the degree of mild-hyperthermic (temperatures between 40 °C and 50 °C) and thermally ablative (TA) effects (temperatures exceeding 50 °C) caused by IRE within the IRE-treated region (IRE-TR).
Methods: A systematic search was performed in medical and technical databases for original studies reporting on numerical simulations of IRE. Data on used equations, study design, tissue models, maximum temperature increase, and surface areas of IRE-TR, mild-hyperthermic, and ablative temperatures were extracted.
Results: Several identified models, including Laplace equation for calculation of electric field distribution, Pennes Bioheat Equation for heat transfer, and Arrhenius model for thermal damage, were applied on various electrode and tissue models. Median duration of combined mild-hyperthermic and TA effects is 20% of the treatment time. Based on the included studies, mild-hyperthermic temperatures occurred in 30% and temperatures ≥50 °C in 5% of the IRE-TR.Conclusions: Simulation results in this review show that significant mild-hyperthermic effects occur in a large part of the IRE-TR, and direct thermal ablation in comparatively small regions. Future studies should aim to optimize clinical IRE protocols, maintaining a maximum irreversible permeabilized region with minimal TA effects.

Entities:  

Keywords:  Irreversible electroporation; mild hyperthermia; numerical analysis; simulation; thermal ablation

Year:  2020        PMID: 32423258     DOI: 10.1080/02656736.2020.1753828

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  6 in total

Review 1.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

2.  A Comparative Modeling Study of Thermal Mitigation Strategies in Irreversible Electroporation Treatments.

Authors:  Kenneth N Aycock; Sabrina N Campelo; Rafael V Davalos
Journal:  J Heat Transfer       Date:  2022-01-18       Impact factor: 1.855

3.  Electroporation-based proteome sampling ex vivo enables the detection of brain melanoma protein signatures in a location proximate to visible tumor margins.

Authors:  Ilai Genish; Batel Gabay; Angela Ruban; Yona Goldshmit; Amrita Singh; Julia Wise; Klimentiy Levkov; Avshalom Shalom; Edward Vitkin; Zohar Yakhini; Alexander Golberg
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

4.  Numerical mesoscale tissue model of electrochemotherapy in liver based on histological findings.

Authors:  Helena Cindric; Gorana Gasljevic; Ibrahim Edhemovic; Erik Brecelj; Jan Zmuc; Maja Cemazar; Alenka Seliskar; Damijan Miklavcic; Bor Kos
Journal:  Sci Rep       Date:  2022-04-20       Impact factor: 4.996

5.  Survival model database of human digestive system cells exposed to electroporation pulses: An in vitro and in silico study.

Authors:  Xuan Han; Nana Zhang; Yuchi Zhang; Zhuoqun Li; Yingxue Wang; Lujing Mao; Tianshuai He; Qingshan Li; Jiawen Zhao; Xue Chen; Yixuan Li; Zitong Qin; Yi Lv; Fenggang Ren
Journal:  Front Public Health       Date:  2022-09-05

6.  Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers.

Authors:  Tomaz Jarm; Tadej Krmac; Ratko Magjarevic; Bor Kos; Helena Cindric; Damijan Miklavcic
Journal:  Biomed Eng Online       Date:  2020-11-16       Impact factor: 2.819

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.